Clinical Trials
79 trialsDevelopment and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
Rigshospitalet, Denmark
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy
Medical College of Wisconsin
UFGAG
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
ERROR
Maastricht Radiation Oncology
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
Thomas Jefferson University
FET-TREAT
Sunnybrook Health Sciences Centre
ONCOhabitats
Universitat Politècnica de València
ALBATROSS
Universitat Politècnica de València
BIOhabitats
Universitat Politècnica de València
Tryptophan Metabolism in Human Brain Tumors-Novocure
Wayne State University
IMMUNOGLIO
Centre Georges Francois Leclerc
ROOT
Taproot Health
BraTioUS-DB
Hospital del Rio Hortega
Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
Novosibirsk State University
PSMAďźASLďźPET
Lanzhou University Second Hospital
GLOIOS
Hopital Nord Franche-Comte
Tumor Treating Fields for Newly Diagnosed Glioblastoma: Two Emulated Trials With Chinese Multi-Hospital Based Real-World Data
Sichuan University
IRD-GBM
University of Manitoba
Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
Asan Medical Center
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC
Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS
Istituto Oncologico Veneto IRCCS
TGEN
University of California, San Francisco
2D-ioUS-Glio
Hospital del Rio Hortega
Biomarkers for Prognosis of Glioblastoma (GBM)
University of Nebraska
Quality of Life and Patient Needs in Advanced High Grade Gliomas
Henry Ford Health System
Glioblastoma Response Prediction to Apatinib
Beijing Sanbo Brain Hospital
Determination of Immune Phenotype in Glioblastoma Patients
University of Ulm
Differentiation Between Healthy Cerebral Tissue and Tumor Tissue Using a Tissue Sensing Instrument
Karolinska University Hospital
Immunophenotyping From Blood of Patients With Malignant Gliomas
University of Erlangen-NĂźrnberg Medical School
Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM)
University of Iowa
BRITER
Brighton and Sussex University Hospitals NHS Trust
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
Massachusetts General Hospital
Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma
University Hospital Regensburg
ACTION
Duke University
Validation of Readiband⢠Actigraph and Associated Sleep/Wake Classification Algorithms
Allina Health System
Specific Preoperative Dynamic Contrast-enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of the Glioblastoma Tissue and Predict Recurrence
Egyptian Medical Syndicate
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Case Comprehensive Cancer Center
GLIOBLASTOMES
Centre Hospitalier Universitaire, Amiens
Intra-operative Variation in Size of Brain Tumors After Craniotomy
Sheri Kashmir Institute of Medical Sciences
Natural History of Patients With Brain and Spinal Cord Tumors
National Institutes of Health Clinical Center (CC)
PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
University of Wisconsin, Madison
Study of Blood and Cheek Cell Samples From Patients With Glioma
University of California, San Francisco
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
Technische Universität Dresden
Study of Tissue and Blood Samples From Patients With High-Grade Glioma
Alliance for Clinical Trials in Oncology
Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma
Eisai Inc.
Radiomics
Maastricht Radiation Oncology
MIRNA
Assistance Publique - HĂ´pitaux de Paris
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins